Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

New US FDA program to help determine if device trials will lead to market approval

This article was originally published in Clinica

Executive Summary

The US Food and Drug Administration is inviting feedback on its plans to create a new voluntary process that would allow device trial sponsors to determine whether their pivotal study design would support a marketing application if it is successfully executed and meets its stated endpoints without raising unforeseen safety concerns.